Single-cell profiling identifies pre-existing CD19-negative subclones in a B-ALL patient with CD19-negative relapse after CAR-T therapy | Nature Communications
Figures and data in A dynamic interaction between CD19 and the tetraspanin CD81 controls B cell co-receptor trafficking | eLife
B Cells
Immunophenotyping of B Cells by Flow Cytometry | Bio-Rad
Phospho-CD19 (Tyr531) Antibody | Cell Signaling Technology
Mature B‐ and plasma‐cell flow cytometric analysis: A review of the impact of targeted therapy - Gao - Cytometry Part B: Clinical Cytometry - Wiley Online Library
CD19 Antibody (Dako Omnis) | Agilent
Flow cytometry analysis of B-cell antigenic surface markers B220 and... | Download Scientific Diagram
International Clinical Cytometry Society
Immunophenotyping Utilizing 6 Color Flow Cytometry - Warde Medical Laboratory
Rat CD19 Antibody AF7489: R&D Systems
View Image
Parallel CD19/CD20 CAR-Activated T-Cells Are More Effective for Refractory B-Cell Lymphoma In Vitro and In Vivo
Cancers | Free Full-Text | CD19 Chimeric Antigen Receptor-Exosome Targets CD19 Positive B-lineage Acute Lymphocytic Leukemia and Induces Cytotoxicity
BV421 Rat Anti-Mouse CD19
Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models | Science Translational Medicine
Establishing CD19 B-cell reference control materials for comparable and quantitative cytometric expression analysis | PLOS ONE
REAlease® CD19 MicroBead Kit, human | B cells | MicroBeads and Isolation Kits | Cell separation reagents | MACS Cell Separation | Products | Miltenyi Biotec | Australia
Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma | Nature Medicine
Cells | Free Full-Text | Altered Phenotype and Enhanced Antibody-Producing Ability of Peripheral B Cells in Mice with Cd19-Driven Cre Expression
APC Anti-Mouse CD19 (1D3) | Cytek Biosciences
Selective B cell depletion upon intravenous infusion of replication-incompetent anti-CD19 CAR lentivirus: Molecular Therapy - Methods & Clinical Development
Table 2 from The role of CD 20 and CD 19 with their flow cytometric parameters in differentiation between Chronic Lymphocytic Leukaemia / Small Lymphocytic Lymphoma and other B-cell Non Hodgkin Lymphoma | Semantic Scholar
Expression of CD5 and CD19 markers in B-cells of patients with chronic... | Download Scientific Diagram
